Cargando…
Glucagon signaling via supraphysiologic GCGR can reduce cell viability without stimulating gluconeogenic gene expression in liver cancer cells
BACKGROUND: Deregulated glucose metabolism is a critical component of cancer growth and survival, clinically evident via FDG-PET imaging of enhanced glucose uptake in tumor nodules. Tumor cells utilize glucose in a variety of interconnected biochemical pathways to generate energy, anabolic precursor...
Autores principales: | Godfrey, Jason, Riscal, Romain, Skuli, Nicolas, Simon, M. Celeste |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817478/ https://www.ncbi.nlm.nih.gov/pubmed/35123542 http://dx.doi.org/10.1186/s40170-022-00280-1 |
Ejemplares similares
-
Glycogen metabolism is dispensable for tumor progression in clear cell renal cell carcinoma
por: Xie, Hong, et al.
Publicado: (2021) -
Glucagon Potentiates Insulin Secretion Via β-Cell GCGR at Physiological Concentrations of Glucose
por: Zhang, Yulin, et al.
Publicado: (2021) -
High glucose-induced glucagon resistance and membrane distribution of GCGR revealed by super-resolution imaging
por: Gao, Jing, et al.
Publicado: (2023) -
Polyomic profiling reveals significant hepatic metabolic alterations in glucagon-receptor (GCGR) knockout mice: implications on anti-glucagon therapies for diabetes
por: Yang, Jianxin, et al.
Publicado: (2011) -
Glucagon receptor-mediated regulation of gluconeogenic gene transcription is endocytosis-dependent in primary hepatocytes
por: Cajulao, Jan Mikhale B., et al.
Publicado: (2022)